Capital CS Group LLC bought a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 2,658 shares of the medical device company’s stock, valued at approximately $301,000. DexCom makes up approximately 0.3% of Capital […]
The global healthcare sector has been permanently transformed by the COVID-19 pandemic, which has resulted in a faster adoption of novel technologies and care delivery methods, as well as a heightened.
DexCom, Inc. (NASDAQ:DXCM – Get Rating) Director Steven Robert Pacelli sold 5,442 shares of the stock in a transaction on Thursday, March 23rd. The stock was sold at an average price of $116.40, for a total value of $633,448.80. Following the completion of the transaction, the director now owns 138,129 shares in the company, valued […]